To enhance the cytotoxic effects of azacitidine on MDS and AML hematopoietic stem cells by impeding the interaction of HMGB1-RAGE and HMGB1-TLR4, and chemokine CXCR4 axis. Here, CXCR4 is linked to myelodysplastic syndrome.